alan, copy of a post sent to me from the IPIX SMB on the

New Post Public Reply Private Reply Replies (0) Message Board
4kids AlanC #60602
426
alan,

copy of a post sent to me from the IPIX SMB on the vehicle of choice for OTC stock manipulation

as i've noted for those who've paid attention .. NRs' playbook in 2019
is both dated and tired .. tellingly it hasn't changed much from 2010

some may recall that site .. deemed Finra's DRS %s as Off Topic when Finra's
link first went live ( Feb 2010 ) .. this was because *embedded crews and NRs'
minions' required *time* to trot out new talking points .. on specific OTC targets
that took about 6 months .. who can forget the years of *NRs' retail CONditioning*
that there was no such thing as any entity shorting an OTC *equity* (forget the
fact of NR abusively shorting any OTC equity) .. that was just one decade back

remember too .. just a year ago the *effort* by an embed about DRS%s *here*

always telling to see Non Retail *conflate* a targeted OTC company & stock
with an exchange traded stock (Apple/J&J noted recently)


there is no comparison to be made .. it is like comparing Apple to Oranges .. the only comparison is both fall into the *fruit* category

equities on the OTC do not compare to exchange traded equities .. no matter how many times *embeds try to blur reality*

as NRs' *efforts* get exposed .. more and more become aware

NRs' trolls and embeds utilize a tactic of repetition to condition by rote ..
repeat something enough times .. it becomes *reality* for some of the public

that is why SMBs can be *revealing* .. when an OTC target outlasts NRs' efforts
and does so without blowing out their I/O .. what you see with a significantly
UPSIDE DOWN NR .. is an SMB (vehicle of choice for OTC stock manipulation is a perfect example) .. with posts that are far more *negative*
than positive .. let alone neutral .. sometimes it is worth noting those %s .. i tend
to work off of 250 posts (5 pages) re: CONtent and percentages

it's also why it's worth noting when *efforts* come here .. in relation to what NR
is forced to do re: hidden trades and DRS %s .. to say nothing of what *volume*
shows (daily/weekly/monthly/YTD/YOY)

below is the tip of the iceberg (or as i call it .. SEC's *effort* re: low hanging fruit)


SEC Charges 18 Traders in $31 Million Stock Manipulation Scheme
FOR IMMEDIATE RELEASE
2019-216

Washington D.C., Oct. 16, 2019 —
The Securities and Exchange Commission has filed an emergency action and obtained an asset freeze against 18 traders in a scheme to manipulate more than 3,000 U.S.-listed securities for over $31 million in illicit profits.

The SEC alleges that the traders, who are primarily based in China, manipulated the prices of thousands of thinly traded securities by creating the false appearance of trading interest and activity in those stocks, thereby enabling them to reap illicit profits by artificially boosting or depressing stock prices. For example, according to the SEC's complaint, the traders used multiple accounts to place several small sell orders to drive down a stock’s price before using a different set of accounts to buy larger amounts of the stock at the artificially low prices. After accumulating their position, the traders then flipped the script and placed several small buy orders to push up prices so they could then sell their stock at artificially high prices.

"We allege that defendants engaged in an extensive manipulation scheme and went to great lengths to evade detection, placing trades in over one hundred separate accounts at several different brokerage firms and submitting falsified documents to open new accounts in the names of others," said Joseph G. Sansone, Chief of the SEC's Market Abuse Unit. "Despite their efforts, the SEC staff was able to uncover the connections between these seemingly unrelated accounts and expose the defendants' coordinated pattern of illicit trading."

In a parallel action, the U.S. Attorney's Office for the District of Massachusetts announced criminal charges against two of the traders, Jiali Wang and Xiaosong Wang.

The SEC's complaint filed in federal court in Boston and unsealed today, charges the traders with violating and aiding and abetting violations of the antifraud provisions of the securities laws. In addition to the asset freeze and other emergency relief obtained, the SEC seeks disgorgement of ill-gotten gains plus interest, penalties, and injunctive relief.

The SEC's investigation was conducted by Andrew Palid and Michele T. Perillo of the SEC's Market Abuse Unit in the Boston Regional Office with assistance from John Marino of the Market Abuse Unit, and was supervised by Mr. Sansone. The litigation will be led by Eric Forni of the Boston Regional Office and Mr. Palid. The SEC appreciates the assistance of the U.S. Attorney's Office for the District of Massachusetts, the Federal Bureau of Investigation, and the Financial Industry Regulatory Authority.


https://www.sec.gov/news/press-release/2019-216

original link courtesy of thepennyguru

Read More: https://investorshangout.com/post/view?id=556...z62i62mHpc

4kids

Pleased to see the SEC taking action and actually bringing criminal charges. Are you going to post this on IPIX?
Alan










Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ardelyx Securities Fraud Suit: Key Investor Moves

Updated Category News Views 5

Fraud Allegations: Ardelyx Under the Microscope Looks like Ardelyx has found itself neck-deep in trouble, facing a class action lawsuit over alleged securities fraud. This isn't just a storm in a teacup. We're talking about accusations of false and misleading statements tied to their commercial performance—statements that might have left investors holding the bag with...

Continue Reading
PrideStaff: 8 Years Strong on Franchise Times Top 400

Updated Category News Views 4

Where PrideStaff Stands in the Franchise Landscape Here's something the staffing world can't ignore: PrideStaff nailed it again, landing among the giants on the Franchise Times Top 400 for the eighth straight year. Sitting at number 217, this ain't just a lucky streak—this is a sustained homerun, my friends. Consistency Is Key, And They're Holding It Consider this...

Continue Reading
Steel Dynamics Gears Up for Q3 2026 Earnings Update

Updated Category News Views 6

Steel Dynamics Preps for Key Earnings Report Folks, we're staring down the barrel of another quarterly earnings report from Steel Dynamics, Inc., and you can bet this one is gonna have plenty of eyes glued. October 19th, 2026, that's when they'll peel back the curtain on how they fared in Q3. Now, buckle up, because this isn't just a numbers game—it’s a snapshot of...

Continue Reading
Newfold Digital Revamps Leadership for Growth Surge

Updated Category News Views 4

Steering into New Horizons with Fresh Leadership October 2026 marks a fresh chapter for Newfold Digital, as they shuffle the deck chairs a bit and ramp up for some ambitious growth endeavors. This web and commerce tech company decided it's time to bring a few heavy hitters on board. Starting this month, watch out for Sachin Puri taking the reins as Chief Executive...

Continue Reading
CME Group Unveils First Baseball Futures Market

Updated Category News Views 6

A New Pitch in the Financial Ballpark Alright, listen up: CME Group is stepping up to the plate with a game-changer. They’re rolling out the world’s first baseball futures, launching October 12, assuming regulators give the green light. Now, this isn’t just some novelty act; it’s based on the solid groundwork of their FutureSports Performance Indexes (CME FSPI),...

Continue Reading
Hexaware Teams with Anthropic for Game-Changing AI Move

Updated Category News Views 4

A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...

Continue Reading
Protecting Your Family on Halloween: Safety Tips

Updated Category News Views 5

Avoid Turning Halloween Fun Into a Medical Emergency Halloween should be about ghosts and ghouls, not a dreaded detour to the ER. Yet, every year, adults and kids get carried away with costumes, only to find themselves in a real-life horror show courtesy of a slip, a fall, or a carving mishap. The American Academy of Orthopaedic Surgeons (AAOS) is waving the safety flag,...

Continue Reading
Lupin Secures FDA Nod for Key Injectable Drug

Updated Category News Views 4

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

Continue Reading
Webull Faces Legal Scrutiny Over Chinese Ties

Updated Category News Views 4

The Unfolding Drama for Webull Shareholders When you see a ticker like NASDAQ:BULL rolling off your tongue these days, it’s not just about stock prices anymore—it's a whole saga wrapped in legal and geopolitical spice. Following the recent uproar from a House China committee report, Webull found itself thrust into the spotlight for all the wrong reasons. That report...

Continue Reading
Striveworks: Boosting Army's AI Edge in Indo-Pacific

Updated Category News Views 6

The world keeps marching forward, and here’s Striveworks stepping up to the plate with another big move in the military tech space. This isn't your average partnership renewal; this involves a five-year, $200 million deal to enhance battlefield AI as the U.S. Army hones its modern warfare edge in the Indo-Pacific. Now, this isn't just a battle of strategies but a battle...

Continue Reading

Top 5 Most Recently Viewed Articles

Medpace Holdings Achieves Impressive Revenue Growth Despite Challenges

Updated Category News Views 187

Medpace Holdings Reports Strong Financial Growth Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent provider of clinical research services, has recently demonstrated impressive financial performance with an 8.3% revenue increase year-over-year, totaling $533.3 million in the third quarter. Net income also surged by 36.7%, reaching $96.4 million. This positive growth comes...

Continue Reading
ECARX Launches Ambitious $20M Share Buyback Initiative

Updated Category News Views 118

ECARX Unveils $20 Million Share Repurchase Plan ECARX Holdings, Inc. (Nasdaq: ECX) is taking a significant step in its financial strategy by launching a share repurchase program valued at up to $20 million. This development indicates the company's commitment to returning value to shareholders while optimizing its capital structure. Details of the Share Repurchase Program...

Continue Reading
Abpro Holdings Marks Major Milestone with Successful IPO Ceremony

Updated Category News Views 163

Abpro Holdings Celebrates Its Successful Business Combination Abpro Holdings, Inc. (Nasdaq:ABP) is excited to announce the completion of its business combination with Atlantic Coastal Acquisition Corp II. A grand bell ringing ceremony at Nasdaq marked this significant achievement, highlighting the dedication and hard work Abpro has put into this journey. Through this...

Continue Reading
Navigating Securities Losses: A Look at Compass Diversified

Updated Category News Views 169

Understanding Your Rights as an Investor Investors in Compass Diversified Holdings (NYSE: CODI) facing substantial losses have a critical opportunity to take action. Many investors find themselves in challenging positions when companies fail to disclose critical financial information. Such scenarios can lead to significant investment losses. Understanding one's rights and...

Continue Reading
Exploring Future Growth in the Blood Glucose Monitoring Market

Updated Category News Views 247

The Rising Demand for Blood Glucose Monitoring Devices As health awareness increases and diabetes continues to affect millions globally, the Blood Glucose Monitoring Device market is set to experience remarkable expansion. Valued at USD 13.49 billion in recent times, this industry is anticipated to grow significantly, reaching around USD 27.61 billion by 2032. This...

Continue Reading